Minerva Neurosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $42 | $42 |
Gross Profit | -1 | -1 | 21 | 21 |
EBITDA | -2,742 | -3,257 | -4,270 | -4,271 |
EBIT | -2,743 | -3,258 | -4,272 | -4,272 |
Net Income | -2,743 | -3,258 | -3,752 | -4,272 |
Net Change In Cash | 0 | 0 | 42 | 42 |
Free Cash Flow | -2,916 | -2,042 | -5,166 | -5,166 |
Cash | 12,286 | 15,247 | 17,290 | 21,362 |
Basic Shares | 7,569 | 7,568 | 7,569 | 7,569 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -22 | -30 | -8 | -102 |
EBITDA | 6,023 | -21,691 | -24,693 | -45,280 |
EBIT | 6,001 | -21,722 | -24,702 | -45,381 |
Net Income | 1,438 | -30,005 | -32,108 | -49,905 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,550 | -14,784 | -24,661 | -24,601 |
Cash | 21,362 | 40,912 | 36,093 | 60,755 |
Basic Shares | 7,574 | 6,506 | 5,340 | 5,340 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.36 |
2025-06-30 | -$0.43 |
2025-03-31 | -$0.50 |
